Advanced Glycation End Products and Oxidative Stress in Type 2 Diabetes Mellitus

被引:798
|
作者
Nowotny, Kerstin [1 ]
Jung, Tobias [1 ]
Hoehn, Annika [1 ]
Weber, Daniela [1 ]
Grune, Tilman [1 ]
机构
[1] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Toxicol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany
来源
BIOMOLECULES | 2015年 / 5卷 / 01期
关键词
advanced glycation end products; oxidative stress; type 2 diabetes mellitus; insulin resistance; cell dysfunction; diabetic complications;
D O I
10.3390/biom5010194
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Type 2 diabetes mellitus (T2DM) is a very complex and multifactorial metabolic disease characterized by insulin resistance and cell failure leading to elevated blood glucose levels. Hyperglycemia is suggested to be the main cause of diabetic complications, which not only decrease life quality and expectancy, but are also becoming a problem regarding the financial burden for health care systems. Therefore, and to counteract the continually increasing prevalence of diabetes, understanding the pathogenesis, the main risk factors, and the underlying molecular mechanisms may establish a basis for prevention and therapy. In this regard, research was performed revealing further evidence that oxidative stress has an important role in hyperglycemia-induced tissue injury as well as in early events relevant for the development of T2DM. The formation of advanced glycation end products (AGEs), a group of modified proteins and/or lipids with damaging potential, is one contributing factor. On the one hand it has been reported that AGEs increase reactive oxygen species formation and impair antioxidant systems, on the other hand the formation of some AGEs is induced per se under oxidative conditions. Thus, AGEs contribute at least partly to chronic stress conditions in diabetes. As AGEs are not only formed endogenously, but also derive from exogenous sources, i.e., food, they have been assumed as risk factors for T2DM. However, the role of AGEs in the pathogenesis of T2DM and diabetic complicationsif they are causal or simply an effectis only partly understood. This review will highlight the involvement of AGEs in the development and progression of T2DM and their role in diabetic complications.
引用
收藏
页码:194 / 222
页数:29
相关论文
共 50 条
  • [21] The Levels and Related Factors of Advanced Glycation End Products in Korean Patients with Type 2 Diabetes Mellitus
    Yim, Jung-Eun
    Kim, Young Seol
    Park, Ji Sook
    DIABETES, 2020, 69
  • [22] Role of advanced glycation end products (AGEs) and oxidative stress in vascular complications in diabetes
    Yamagishi, Sho-ichi
    Maeda, Sayaka
    Matsui, Takanori
    Ueda, Seiji
    Fukami, Kei
    Okuda, Seiya
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 1820 (05): : 663 - 671
  • [23] Effects of Resveratrol on Receptor for Advanced Glycation End Products (RAGE) Expression and Oxidative Stress in the Liver of Rats with Type 2 Diabetes
    Khazaei, Mohammad
    Karimi, Jamshid
    Sheikh, Nasrin
    Goodarzi, Mohammad Taghi
    Saidijam, Massoud
    Khodadadi, Iraj
    Moridi, Heresh
    PHYTOTHERAPY RESEARCH, 2016, 30 (01) : 66 - 71
  • [24] Decreased levels of soluble receptor for advanced glycation end products in type 2 diabetes:: Association with oxidative stress and metabolic control
    Santilli, F.
    Devangelio, E.
    Formoso, G.
    Ferroni, R.
    Bucciarelli, L.
    Mchetti, N.
    Clissa, C.
    Ciabattoni, G.
    Consoli, A.
    Davi, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 355 - 355
  • [25] Advanced glycation end products and endothelial dysfunction in type 2 diabetes
    Tan, KCB
    Chow, WS
    Ai, VHG
    Metz, C
    Bucala, R
    Lam, KSL
    DIABETES CARE, 2002, 25 (06) : 1055 - 1059
  • [26] Oxidative and Advanced Glycation End Products Predict Cardiovascular Disease in Type 1 Diabetes
    Beisswenger, Paul J.
    Bebu, Ionut
    Howell, Scott
    Pan, Helen
    Lachin, John M.
    DIABETES, 2017, 66 : A117 - A117
  • [27] Advanced glycation end products, oxidative stress and diabetic nephropathy
    Yamagishi, Sho-ichi
    Matsui, Takanori
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2010, 3 (02) : 101 - 108
  • [28] Serum level of soluble receptor for advanced glycation end products is associated with circulating advanced glycation end products in type 2 diabetes
    Tan, K. C. B.
    Chow, W. S.
    Shiu, S. W. M.
    Bucala, R.
    Betteridge, D. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 294 - 294
  • [30] Advanced glycation end products and glutathione status in patients with type 2 diabetes mellitus and macroangiopathy of the lower limbs
    Shemyakina, Nadezhda A.
    Namokonov, Evgeny V.
    Darenskaya, Marina A.
    Kolesnikov, Sergey I.
    Kolesnikova, Lyubov I.
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 120 : S60 - S61